Back

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Science in Atrial Fibrillation 2 Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

4 More presentations in this session

Presentation thumbnail
Integrated management of atrial fibrillation in primary care: the ALL-IN cluster randomised trial
Ms C. Van Den Dries (Utrecht, NL)
Presentation thumbnail
Opportunistic screening for atrial fibrillation versus routine care in older persons in the community: findings from a dutch nationwide primary care-based cluster randomised clinical trial
Mr S. Uittenbogaart (Amsterdam, NL)
Presentation thumbnail
A home-based education and learning program for atrial fibrillation: the HELP-AF study
Professor P. Sanders (Adelaide, AU)
Slides Video
Presentation thumbnail
Randomised clinical trial of nurse-led integrated care for atrial fibrillation, a comparison with care as usual provided by the cardiologist
Professor H. Crijns (Maastricht, NL) Ms P. Wijtvliet (Maastricht, NL)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Atrial Fibrillation 2

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources